News
Assembly Biosciences, Inc. Data demonstrating nanomolar potency of core inhibitor ABI-4334 to disrupt the hepatitis B virus (HBV) life cycle at multiple points supports advancement into clinical ...
Assembly Biosciences, Inc. – Data from both ABI-5366 and ABI-1179, novel long-acting helicase-primase inhibitor candidates for recurrent genital herpes, to be presented – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback